CureSPG50

CureSPG50 funds research and support services for spastic paraplegia type 50, a rare genetic neurological disorder that causes progressive muscle weakness and mobility loss. The foundation provides grants to scientists investigating potential treatments and cures while also supporting affected individuals and families through educational resources, patient networks, and financial assistance for medical care. Operating in East York and across the Greater Toronto Area, CureSPG50 bridges the gap between patients seeking answers and researchers working toward breakthroughs in this understudied condition. By directing resources to both laboratory discovery and direct patient support, the foundation addresses the urgent need for progress in a disease where few treatment options currently exist.